Table of Content



Chapter 1 Methodology and Scope
1.1 Market Segmentation
1.1.1 Estimates and Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 Secondary Sources
1.3.3 Primary Research
1.3.4 Details of Primary Research
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis
1.6.1.1 Approach 1: Commodity flow approach
1.6.1.2 Approach 2: Country wise market estimation using bottom up approach
1.7 Global Market: CAGR Calculation
1.8 Research Assumptions
1.9 List of Secondary Sources
1.10 List of Primary Sources
1.11 Objectives
1.11.1 Objective 1:
1.11.2 Objective 2:
1.12 List of Abbreviations
Chapter 2 Executive Summary
2.1 Market Summary
Chapter 3 Molecular Diagnostics Market Variables, Trends & Scope
3.1 Molecular Diagnostics Market Lineage Outlook
3.1.1 Parent market outlook
3.2 Penetration & Growth Prospect Mapping
3.3 Regulatory and Reimbursement Framework
3.4 CLIA Waived Tests and Instruments
3.5 Market Dynamics
3.5.1 Market Driver Analysis
3.5.1.1 Increase in geriatric population
3.5.1.2 Introduction of technologically advanced products
3.5.1.3 Increase in demand for point-of-care facilities
3.5.1.4 Growing prevalence of target diseases
3.5.1.5 Increasing external funding for R&D
3.5.1.6 Outbreak of COVID-19
3.5.2 Market Restraint Analysis
3.5.2.1 Presence of ambiguous regulatory framework
3.5.2.2 High prices of molecular diagnostics tests
3.6 Molecular Diagnostics Market Analysis Tools
3.6.1 Porter’s Five Forces Analysis
3.6.2 SWOT Analysis; By factor (Political & Legal, Economic and Technological)
3.6.3 Major Deals & Strategic Alliances Analysis
3.6.3.1 New product launch
3.6.3.2 Mergers and acquisitions
3.6.3.3 Expansion
3.6.3.4 Partnerships
3.6.3.5 Marketing & promotions
3.6.3.6 Market entry strategies
Chapter 4 Molecular Diagnostics Market - Competitive Analysis
4.1 Recent Developments & Impact Analysis, by Key Market Participants
4.1.1 Company/Competition Categorization (Key innovators, Market leaders, Expansion)
4.1.2 Innovators
4.1.3 Key Differentiators
4.2 Vendor Landscape
4.2.1 List of key distributors
4.2.2 Key Company Market Share Analysis, 2020
4.2.2.1 Market share analysis, by Application, 2020
4.2.2.1.1 Market share analysis, Molecular diagnostics, Oncology, 2020
4.2.2.1.2 Market share analysis, Molecular diagnostics, Pharmacogenomics, 2020
4.2.2.1.3 Market share analysis, Molecular diagnostics, Infectious Diseases, 2020
4.2.2.1.4 Market share analysis, Molecular diagnostics, Genetic Testing, 2020
4.2.2.1.5 Market share analysis, Molecular diagnostics, Others (Neurological disease, Cardiovascular Diseases, Microbiology, Others) 2020
4.2.2.2 Market share analysis, by Technology, 2020
4.2.2.2.1 Market share analysis, Molecular diagnostics, Polymerase Chain Reaction, 2020
4.2.2.2.2 Market share analysis, Molecular diagnostics, In Situ Hybridization, 2020
4.2.2.2.3 Market share analysis, Molecular diagnostics, INAAT, 2020
4.2.2.2.4 Market share analysis, Molecular diagnostics, Chips & Microarrays, 2020
4.2.2.2.5 Market share analysis, Molecular diagnostics, Mass Spectrometry, 2020
4.2.2.2.6 Market share analysis, Molecular diagnostics, Sequencing, 2020
4.2.2.2.7 Market share analysis, Molecular diagnostics, Transcription Mediated Amplification, 2020
4.2.2.3 Market share analysis, by Application, 2020
4.2.2.3.1 Market share analysis, Molecular diagnostics, Oncology, 2020
4.2.2.3.2 Market share analysis, Molecular diagnostics, Pharmacogenomics, 2020
4.2.2.3.3 Market share analysis, Molecular diagnostics, Infectious Diseases, 2020
4.2.2.3.4 Market share analysis, Molecular diagnostics, Genetic Testing, 2020
4.2.2.3.5 Market share analysis, Molecular diagnostics, Others (Neurological disease, Cardiovascular Diseases, Microbiology, Others) 2020
4.2.2.4 Market share analysis, by Technology, 2020
4.2.2.4.1 Market share analysis, Molecular diagnostics, Polymerase Chain Reaction, 2020
4.2.2.4.2 Market share analysis, Molecular diagnostics, In Situ Hybridization, 2020
4.2.2.4.3 Market share analysis, Molecular diagnostics, INAAT, 2020
4.2.2.4.4 Market share analysis, Molecular diagnostics, Chips & Microarrays, 2020
4.2.2.4.5 Market share analysis, Molecular diagnostics, Mass Spectrometry, 2020
4.2.2.4.6 Market share analysis, Molecular diagnostics, Sequencing, 2020
4.2.2.4.7 Market share analysis, Molecular diagnostics, Transcription Mediated Amplification, 2020
4.2.2.5 Market share analysis, by Application, 2020
4.2.2.5.1 Market share analysis, Molecular diagnostics, Oncology, 2020
4.2.2.5.2 Market share analysis, Molecular diagnostics, Pharmacogenomics, 2020
4.2.2.5.3 Market share analysis, Molecular diagnostics, Infectious Diseases, 2020
4.2.2.5.4 Market share analysis, Molecular diagnostics, Genetic Testing, 2020
4.2.2.5.5 Market share analysis, Molecular diagnostics, Others (Neurological disease, Cardiovascular Diseases, Microbiology, Others) 2020
4.2.2.6 Market share analysis, by Technology, 2020
4.2.2.6.1 Market share analysis, Molecular diagnostics, Polymerase Chain Reaction, 2020
4.2.2.6.2 Market share analysis, Molecular diagnostics, In Situ Hybridization, 2020
4.2.2.6.3 Market share analysis, Molecular diagnostics, INAAT, 2020
4.2.2.6.4 Market share analysis, Molecular diagnostics, Chips & Microarrays, 2020
4.2.2.6.5 Market share analysis, Molecular diagnostics, Mass Spectrometry, 2020
4.2.2.6.6 Market share analysis, Molecular diagnostics, Sequencing, 2020
4.2.2.6.7 Market share analysis, Molecular diagnostics, Transcription Mediated Amplification, 2020
4.2.2.7 Market share analysis, by Application, 2020
4.2.2.7.1 Market share analysis, Molecular diagnostics, Oncology, 2020
4.2.2.7.2 Market share analysis, Molecular diagnostics, Pharmacogenomics, 2020
4.2.2.7.3 Market share analysis, Molecular diagnostics, Infectious Diseases, 2020
4.2.2.7.4 Market share analysis, Molecular diagnostics, Genetic Testing, 2020
4.2.2.7.5 Market share analysis, Molecular diagnostics, Others (Neurological disease, Cardiovascular Diseases, Microbiology, Others) 2020
4.2.2.8 Market share analysis, by Technology, 2020
4.2.2.8.1 Market share analysis, Molecular diagnostics, Polymerase Chain Reaction, 2020
4.2.2.8.2 Market share analysis, Molecular diagnostics, In Situ Hybridization, 2020
4.2.2.8.3 Market share analysis, Molecular diagnostics, INAAT, 2020
4.2.2.8.4 Market share analysis, Molecular diagnostics, Chips & Microarrays, 2020
4.2.2.8.5 Market share analysis, Molecular diagnostics, Mass Spectrometry, 2020
4.2.2.8.6 Market share analysis, Molecular diagnostics, Sequencing, 2020
4.2.2.8.7 Market share analysis, Molecular diagnostics, Transcription Mediated Amplification, 2020
4.2.2.9 Market share analysis, by Application, 2020
4.2.2.9.1 Market share analysis, Molecular diagnostics, Oncology, 2020
4.2.2.9.2 Market share analysis, Molecular diagnostics, Pharmacogenomics, 2020
4.2.2.9.3 Market share analysis, Molecular diagnostics, Infectious Diseases, 2020
4.2.2.9.4 Market share analysis, Molecular diagnostics, Genetic Testing, 2020
4.2.2.9.5 Market share analysis, Molecular diagnostics, Others (Neurological disease, Cardiovascular Diseases, Microbiology, Others) 2020
4.2.2.10 Market share analysis, by Technology, 2020
4.2.2.10.1 Market share analysis, Molecular diagnostics, Polymerase Chain Reaction, 2020
4.2.2.10.2 Market share analysis, Molecular diagnostics, In Situ Hybridization, 2020
4.2.2.10.3 Market share analysis, Molecular diagnostics, INAAT, 2020
4.2.2.10.4 Market share analysis, Molecular diagnostics, Chips & Microarrays, 2020
4.2.2.10.5 Market share analysis, Molecular diagnostics, Mass Spectrometry, 2020
4.2.2.10.6 Market share analysis, Molecular diagnostics, Sequencing, 2020
4.2.2.10.7 Market share analysis, Molecular diagnostics, Transcription Mediated Amplification, 2020
4.2.2.11 Market share analysis, by Application, 2020
4.2.2.11.1 Market share analysis, Molecular diagnostics, Oncology, 2020
4.2.2.11.2 Market share analysis, Molecular diagnostics, Pharmacogenomics, 2020
4.2.2.11.3 Market share analysis, Molecular diagnostics, Infectious Diseases, 2020
4.2.2.11.4 Market share analysis, Molecular diagnostics, Genetic Testing, 2020
4.2.2.11.5 Market share analysis, Molecular diagnostics, Others (Neurological disease, Cardiovascular Diseases, Microbiology, Others) 2020
4.2.2.12 Market share analysis, by Technology, 2020
4.2.2.12.1 Market share analysis, Molecular diagnostics, Polymerase Chain Reaction, 2020
4.2.2.12.2 Market share analysis, Molecular diagnostics, In Situ Hybridization, 2020
4.2.2.12.3 Market share analysis, Molecular diagnostics, INAAT, 2020
4.2.2.12.4 Market share analysis, Molecular diagnostics, Chips & Microarrays, 2020
4.2.2.12.5 Market share analysis, Molecular diagnostics, Mass Spectrometry, 2020
4.2.2.12.6 Market share analysis, Molecular diagnostics, Sequencing, 2020
4.2.2.12.7 Market share analysis, Molecular diagnostics, Transcription Mediated Amplification, 2020
4.3 Public Companies
4.3.1 Company Market Position Analysis (2020)
4.3.2 Competitive Dashboard Analysis
4.4 Private Companies
4.4.1 List of Key Emerging Companies /Technology Disruptors/Innovators
4.4.2 Regional Network Map
4.4.3 Competitive Dashboard Analysis
Chapter 5 Products Business Analysis
5.1 Molecular Diagnostics Market: Products Movement Analysis
5.1.1 Instruments
5.1.1.1 Instruments market estimates and forecast, 2017 - 2028 (USD Million)
5.1.2 Reagents
5.1.2.1 Reagents market estimates and forecast, 2017 - 2028 (USD Million)
5.1.3 Others
5.1.3.1 Others market estimates and forecast, 2017 - 2028 (USD Million)
Chapter 6 Test Location Business Analysis
6.1 Molecular Diagnostics Market: Test Location Movement Analysis
6.1.1 Point-of-Care
6.1.1.1 Point-of-care market estimates and forecast, 2017 - 2028 (USD Million)
6.1.2 Self-testing or Over the Counter
6.1.2.1 Self-testing or over the counter market estimates and forecast, 2017 - 2028 (USD Million)
6.1.3 Central Laboratories
6.1.3.1 Central laboratories market estimates and forecast, 2017 - 2028 (USD Million)



List of Tables



TABLE 1 Country share estimation
TABLE 2 North America molecular diagnostics market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 3 North America molecular diagnostics market estimates and forecasts, by test location, 2017 - 2028 (USD Million)
TABLE 4 North America molecular diagnostics market estimates and forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 5 North America PCR market estimates and forecasts, by type, 2017 - 2028 (USD Million)
TABLE 6 North America PCR market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 7 North America ISH market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 8 North America INAAT market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 9 North America chips and microarrays market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 10 North America mass spectrometry market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 11 North America sequencing market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 12 North America TMA market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 13 North America others technology market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 14 North America molecular diagnostics market estimates and forecasts, by application, 2017 - 2028 (USD Million)
TABLE 15 North America molecular diagnostics market estimates and forecasts, by oncology, 2017 - 2028 (USD Million)
TABLE 16 North America molecular diagnostics market estimates and forecasts, by infectious diseases, 2017 - 2028 (USD Million)
TABLE 17 North America molecular diagnostics market estimates and forecasts, by genetic testing, 2017 - 2028 (USD Million)
TABLE 18 U.S. molecular diagnostics market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 19 U.S. molecular diagnostics market estimates and forecasts, by test location, 2017 - 2028 (USD Million)
TABLE 20 U.S. molecular diagnostics market estimates and forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 21 U.S. PCR market estimates and forecasts, by type, 2017 - 2028 (USD Million)
TABLE 22 U.S. PCR market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 23 U.S. ISH market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 24 U.S. INAAT market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 25 U.S. chips and microarrays market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 26 U.S. mass spectrometry market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 27 U.S. sequencing market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 28 U.S. TMA market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 29 U.S. others technology market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 30 U.S. molecular diagnostics market estimates and forecasts, by application, 2017 - 2028 (USD Million)
TABLE 31 U.S. molecular diagnostics market estimates and forecasts, by oncology, 2017 - 2028 (USD Million)
TABLE 32 U.S. molecular diagnostics market estimates and forecasts, by infectious diseases, 2017 - 2028 (USD Million)
TABLE 33 U.S. molecular diagnostics market estimates and forecasts, by genetic testing, 2017 - 2028 (USD Million)
TABLE 34 Canada molecular diagnostics market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 35 Canada molecular diagnostics market estimates and forecasts, by test location, 2017 - 2028 (USD Million)
TABLE 36 Canada molecular diagnostics market estimates and forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 37 Canada PCR market estimates and forecasts, by type, 2017 - 2028 (USD Million)
TABLE 38 Canada PCR market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 39 Canada ISH market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 40 Canada INAAT market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 41 Canada chips and microarrays market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 42 Canada mass spectrometry market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 43 Canada sequencing market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 44 Canada TMA market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 45 Canada others technology market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 46 Canada molecular diagnostics market estimates and forecasts, by application, 2017 - 2028 (USD Million)
TABLE 47 Canada molecular diagnostics market estimates and forecasts, by oncology, 2017 - 2028 (USD Million)
TABLE 48 Canada molecular diagnostics market estimates and forecasts, by infectious diseases, 2017 - 2028 (USD Million)
TABLE 49 Canada molecular diagnostics market estimates and forecasts, by genetic testing, 2017 - 2028 (USD Million)
TABLE 50 Europe molecular diagnostics market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 51 Europe molecular diagnostics market estimates and forecasts, by test location, 2017 - 2028 (USD Million)
TABLE 52 Europe molecular diagnostics market estimates and forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 53 Europe PCR market estimates and forecasts, by type, 2017 - 2028 (USD Million)
TABLE 54 Europe PCR market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 55 Europe ISH market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 56 Europe INAAT market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 57 Europe chips and microarrays market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 58 Europe mass spectrometry market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 59 Europe sequencing market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 60 Europe TMA market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 61 Europe others technology market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 62 Europe molecular diagnostics market estimates and forecasts, by application, 2017 - 2028 (USD Million)
TABLE 63 Europe molecular diagnostics market estimates and forecasts, by oncology, 2017 - 2028 (USD Million)
TABLE 64 Europe molecular diagnostics market estimates and forecasts, by infectious diseases, 2017 - 2028 (USD Million)
TABLE 65 Europe molecular diagnostics market estimates and forecasts, by genetic testing, 2017 - 2028 (USD Million)
TABLE 66 U.K. molecular diagnostics market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 67 U.K. molecular diagnostics market estimates and forecasts, by test location, 2017 - 2028 (USD Million)
TABLE 68 U.K. molecular diagnostics market estimates and forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 69 U.K. PCR market estimates and forecasts, by type, 2017 - 2028 (USD Million)
TABLE 70 U.K. PCR market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 71 U.K. ISH market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 72 U.K. INAAT market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 73 U.K. chips and microarrays market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 74 U.K. mass spectrometry market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 75 U.K. sequencing market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 76 U.K. TMA market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 77 U.K. others technology market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 78 U.K. molecular diagnostics market estimates and forecasts, by application, 2017 - 2028 (USD Million)
TABLE 79 U.K. molecular diagnostics market estimates and forecasts, by oncology, 2017 - 2028 (USD Million)
TABLE 80 U.K. molecular diagnostics market estimates and forecasts, by infectious diseases, 2017 - 2028 (USD Million)
TABLE 81 U.K. molecular diagnostics market estimates and forecasts, by genetic testing, 2017 - 2028 (USD Million)
TABLE 82 Germany molecular diagnostics market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 83 Germany molecular diagnostics market estimates and forecasts, by test location, 2017 - 2028 (USD Million)
TABLE 84 Germany molecular diagnostics market estimates and forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 85 Germany PCR market estimates and forecasts, by type, 2017 - 2028 (USD Million)
TABLE 86 Germany PCR market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 87 Germany ISH market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 88 Germany INAAT market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 89 Germany chips and microarrays market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 90 Germany mass spectrometry market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 91 Germany sequencing market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 92 Germany TMA market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 93 Germany others technology market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 94 Germany molecular diagnostics market estimates and forecasts, by application, 2017 - 2028 (USD Million)
TABLE 95 Germany molecular diagnostics market estimates and forecasts, by oncology, 2017 - 2028 (USD Million)
TABLE 96 Germany molecular diagnostics market estimates and forecasts, by infectious diseases, 2017 - 2028 (USD Million)
TABLE 97 Germany molecular diagnostics market estimates and forecasts, by genetic testing, 2017 - 2028 (USD Million)
TABLE 98 France molecular diagnostics market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 99 France molecular diagnostics market estimates and forecasts, by test location, 2017 - 2028 (USD Million)
TABLE 100 France molecular diagnostics market estimates and forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 101 France PCR market estimates and forecasts, by type, 2017 - 2028 (USD Million)
TABLE 102 France PCR market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 103 France ISH market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 104 France INAAT market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 105 France chips and microarrays market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 106 France mass spectrometry market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 107 France sequencing market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 108 France TMA market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 109 France others technology market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 110 France molecular diagnostics market estimates and forecasts, by application, 2017 - 2028 (USD Million)
TABLE 111 France molecular diagnostics market estimates and forecasts, by oncology, 2017 - 2028 (USD Million)
TABLE 112 France molecular diagnostics market estimates and forecasts, by infectious diseases, 2017 - 2028 (USD Million)
TABLE 113 France molecular diagnostics market estimates and forecasts, by genetic testing, 2017 - 2028 (USD Million)
TABLE 114 Spain molecular diagnostics market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 115 Spain molecular diagnostics market estimates and forecasts, by test location, 2017 - 2028 (USD Million)
TABLE 116 Spain molecular diagnostics market estimates and forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 117 Spain PCR market estimates and forecasts, by type, 2017 - 2028 (USD Million)
TABLE 118 Spain PCR market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 119 Spain ISH market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 120 Spain INAAT market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 121 Spain chips and microarrays market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 122 Spain mass spectrometry market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 123 Spain sequencing market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 124 Spain TMA market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 125 Spain others technology market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 126 Spain molecular diagnostics market estimates and forecasts, by application, 2017 - 2028 (USD Million)
TABLE 127 Spain molecular diagnostics market estimates and forecasts, by oncology, 2017 - 2028 (USD Million)
TABLE 128 Spain molecular diagnostics market estimates and forecasts, by infectious diseases, 2017 - 2028 (USD Million)
TABLE 129 Spain molecular diagnostics market estimates and forecasts, by genetic testing, 2017 - 2028 (USD Million)
TABLE 130 Italy molecular diagnostics market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 131 Italy molecular diagnostics market estimates and forecasts, by test location, 2017 - 2028 (USD Million)
TABLE 132 Italy molecular diagnostics market estimates and forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 133 Italy PCR market estimates and forecasts, by type, 2017 - 2028 (USD Million)
TABLE 134 Italy PCR market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 135 Italy ISH market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 136 Italy INAAT market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 137 Italy chips and microarrays market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 138 Italy mass spectrometry market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 139 Italy sequencing market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 140 Italy TMA market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 141 Italy others technology market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 142 Italy molecular diagnostics market estimates and forecasts, by application, 2017 - 2028 (USD Million)
TABLE 143 Italy molecular diagnostics market estimates and forecasts, by oncology, 2017 - 2028 (USD Million)
TABLE 144 Italy molecular diagnostics market estimates and forecasts, by infectious diseases, 2017 - 2028 (USD Million)
TABLE 145 Italy molecular diagnostics market estimates and forecasts, by genetic testing, 2017 - 2028 (USD Million)
TABLE 146 Belgium molecular diagnostics market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 147 Belgium molecular diagnostics market estimates and forecasts, by test location, 2017 - 2028 (USD Million)
TABLE 148 Belgium molecular diagnostics market estimates and forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 149 Belgium PCR market estimates and forecasts, by type, 2017 - 2028 (USD Million)
TABLE 150 Belgium PCR market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 151 Belgium ISH market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 152 Belgium INAAT market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 153 Belgium chips and microarrays market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 154 Belgium mass spectrometry market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 155 Belgium sequencing market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 156 Belgium TMA market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 157 Belgium others technology market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 158 Belgium molecular diagnostics market estimates and forecasts, by application, 2017 - 2028 (USD Million)
TABLE 159 Belgium molecular diagnostics market estimates and forecasts, by oncology, 2017 - 2028 (USD Million)
TABLE 160 Belgium molecular diagnostics market estimates and forecasts, by infectious diseases, 2017 - 2028 (USD Million)
TABLE 161 Belgium molecular diagnostics market estimates and forecasts, by genetic testing, 2017 - 2028 (USD Million)
TABLE 162 Switzerland molecular diagnostics market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 163 Switzerland molecular diagnostics market estimates and forecasts, by test location, 2017 - 2028 (USD Million)
TABLE 164 Switzerland molecular diagnostics market estimates and forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 165 Switzerland PCR market estimates and forecasts, by type, 2017 - 2028 (USD Million)
TABLE 166 Switzerland PCR market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 167 Switzerland ISH market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 168 Switzerland INAAT market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 169 Switzerland chips and microarrays market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 170 Switzerland mass spectrometry market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 171 Switzerland sequencing market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 172 Switzerland TMA market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 173 Switzerland others technology market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 174 Switzerland molecular diagnostics market estimates and forecasts, by application, 2017 - 2028 (USD Million)
TABLE 175 Switzerland molecular diagnostics market estimates and forecasts, by oncology, 2017 - 2028 (USD Million)
TABLE 176 Switzerland molecular diagnostics market estimates and forecasts, by infectious diseases, 2017 - 2028 (USD Million)
TABLE 177 Switzerland molecular diagnostics market estimates and forecasts, by genetic testing, 2017 - 2028 (USD Million)
TABLE 178 Netherlands molecular diagnostics market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 179 Netherlands molecular diagnostics market estimates and forecasts, by test location, 2017 - 2028 (USD Million)
TABLE 180 Netherlands molecular diagnostics market estimates and forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 181 Netherlands PCR market estimates and forecasts, by type, 2017 - 2028 (USD Million)
TABLE 182 Netherlands PCR market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 183 Netherlands ISH market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 184 Netherlands INAAT market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 185 Netherlands chips and microarrays market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 186 Netherlands mass spectrometry market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 187 Netherlands sequencing market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 188 Netherlands TMA market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 189 Netherlands others technology market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 190 Netherlands molecular diagnostics market estimates and forecasts, by application, 2017 - 2028 (USD Million)
TABLE 191 Netherlands molecular diagnostics market estimates and forecasts, by oncology, 2017 - 2028 (USD Million)
TABLE 192 Netherlands molecular diagnostics market estimates and forecasts, by infectious diseases, 2017 - 2028 (USD Million)
TABLE 193 Netherlands molecular diagnostics market estimates and forecasts, by genetic testing, 2017 - 2028 (USD Million)
TABLE 194 Poland molecular diagnostics market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 195 Poland molecular diagnostics market estimates and forecasts, by test location, 2017 - 2028 (USD Million)
TABLE 196 Poland molecular diagnostics market estimates and forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 197 Poland PCR market estimates and forecasts, by type, 2017 - 2028 (USD Million)
TABLE 198 Poland PCR market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 199 Poland ISH market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 200 Poland INAAT market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 201 Poland chips and microarrays market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 202 Poland mass spectrometry market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 203 Poland sequencing market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 204 Poland TMA market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 205 Poland others technology market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 206 Poland molecular diagnostics market estimates and forecasts, by application, 2017 - 2028 (USD Million)
TABLE 207 Poland molecular diagnostics market estimates and forecasts, by oncology, 2017 - 2028 (USD Million)
TABLE 208 Poland molecular diagnostics market estimates and forecasts, by infectious diseases, 2017 - 2028 (USD Million)
TABLE 209 Poland molecular diagnostics market estimates and forecasts, by genetic testing, 2017 - 2028 (USD Million)
TABLE 210 Austria molecular diagnostics market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 211 Austria molecular diagnostics market estimates and forecasts, by test location, 2017 - 2028 (USD Million)
TABLE 212 Austria molecular diagnostics market estimates and forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 213 Austria PCR market estimates and forecasts, by type, 2017 - 2028 (USD Million)
TABLE 214 Austria PCR market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 215 Austria ISH market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 216 Austria INAAT market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 217 Austria chips and microarrays market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 218 Austria mass spectrometry market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 219 Austria sequencing market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 220 Austria TMA market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 221 Austria others technology market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 222 Austria molecular diagnostics market estimates and forecasts, by application, 2017 - 2028 (USD Million)
TABLE 223 Austria molecular diagnostics market estimates and forecasts, by oncology, 2017 - 2028 (USD Million)
TABLE 224 Austria molecular diagnostics market estimates and forecasts, by infectious diseases, 2017 - 2028 (USD Million)
TABLE 225 Austria molecular diagnostics market estimates and forecasts, by genetic testing, 2017 - 2028 (USD Million)
TABLE 226 Greece molecular diagnostics market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 227 Greece molecular diagnostics market estimates and forecasts, by test location, 2017 - 2028 (USD Million)
TABLE 228 Greece molecular diagnostics market estimates and forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 229 Greece PCR market estimates and forecasts, by type, 2017 - 2028 (USD Million)
TABLE 230 Greece PCR market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 231 Greece ISH market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 232 Greece INAAT market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 233 Greece chips and microarrays market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 234 Greece mass spectrometry market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 235 Greece sequencing market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 236 Greece TMA market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 237 Greece others technology market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 238 Greece molecular diagnostics market estimates and forecasts, by application, 2017 - 2028 (USD Million)
TABLE 239 Greece molecular diagnostics market estimates and forecasts, by oncology, 2017 - 2028 (USD Million)
TABLE 240 Greece molecular diagnostics market estimates and forecasts, by infectious diseases, 2017 - 2028 (USD Million)
TABLE 241 Greece molecular diagnostics market estimates and forecasts, by genetic testing, 2017 - 2028 (USD Million)
TABLE 242 Sweden molecular diagnostics market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 243 Sweden molecular diagnostics market estimates and forecasts, by test location, 2017 - 2028 (USD Million)
TABLE 244 Sweden molecular diagnostics market estimates and forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 245 Sweden PCR market estimates and forecasts, by type, 2017 - 2028 (USD Million)
TABLE 246 Sweden PCR market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 247 Sweden ISH market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 248 Sweden INAAT market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 249 Sweden chips and microarrays market estimates and forecasts, by product, 2017 - 2028 (USD Million)
TABLE 250 Sweden mass spectrometry market estimates and forecasts, by product, 2017 - 2028 (USD Million)